Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) | PAR-21-109 | NIA | The purpose of this funding opportunity announcement is to provide tailored support for early stage investigators (ESIs) to initiate basic or translational research with nonhuman primates (NHPs).… More | ||
| NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 - Independent Clinical Trial Not Allowed) | RFA-AG-24-013 | NIA | It is essential to expand and diversify the skilled Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) research workforce and provide exposure to AD/ADRD research to… More | ||
| NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed) | RFA-AG-24-012 | NIA | It is essential to expand and diversify the skilled Alzheimers Disease and Alzheimers Disease and Related Dementias (AD/ADRD) research workforce and provide exposure to AD/ADRD research to… More | ||
| Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumulation in Tauopathies (R01 Clinical Trial Not Allowed) | RFA-AG-25-017 | NIA | This funding opportunity invites innovative research proposals to explore the accumulation of misprocessed proteins in Tauopathies within specific brain regions and cell types. We encourage… More | ||
| Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) | RFA-AG-25-016 | NIA | The purpose of this funding opportunity is to invite applications proposing to establish multi-scale computational models recapitulating dynamic changes associated with aging and Alzheimers disease… More | ||
| Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed) | RFA-AG-25-012 | NIA | This NOFO invites applications for the Nathan Shock Centers of Excellence in Basic Biology of Aging (NSC). These Center grants will provide funding for leadership, training, research, and outreach… More | ||
| Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trail Not Allowed) | RFA-AG-25-005 | NIA | This Notice of Funding Opportunity (NOFO) invites U24 Cooperative Agreement applications that propose to establish a national Open Measurement Coordinating Network for Non-Pharmacological Alzheimer… More | ||
| Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed) | RFA-AG-25-013 | NIA | This Notice of Funding Opportunity Announcement (NOFO) invites applications to develop and maintain a (NSC3). The goal of the NSC3 is to provide logistical and organization support of the NSC.… More | ||
| Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) | RFA-AG-25-002 | NIA | This Notice of Funding Opportunity (NOFO) invites applications for a U54 Specialized Center (henceforth: Consortium) to provide resources, expertise, and coordination to advance innovative, high-… More | ||
| NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) | PAR-21-220 | NIA | The purpose of this Funding Opportunity Announcement (FOA) is to diversify the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).… More |